Chelation and determination of labile iron in primary hepatocytes by pyridinone fluorescent probes

Biochemical Journal

Volumn 395, Issue 1, 2006, Pages 49-55

  Ma, Yongmin ^a   De Groot, Herbert ^b   Liu, Zudong ^a   Hider, Robert C ^a   Petrat, Frank ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

3 hydroxypyridin 4 one (HPO) fluorescent probe; Fluorescence microscopy; Hepatocyte; Intracellular labile iron; Iron chelator; Quenching

Indexed keywords

CELLS; CONDITION MONITORING; FLUORESCENCE; IRON COMPOUNDS; KETONES; QUENCHING; SYNTHESIS (CHEMICAL);

3-HYDROXYPYRIDIN-4-ONE (HPO) FLUORESCENT PROBE; FLUORESCENCE MICROSCOPY; HEPATOCYTE; INTRACELLULAR LABILE IRON; IRON CHELATOR;

CHELATION;

1,2 DIETHYL 3 HYDROXY 4 PYRIDONE; 3 HYDROXY 4 PYRIDONE DERIVATIVE; 7 DIETHYLAMINO N [(5 HYDROXY 6 METHYL 4 OXO 1,4 DIHYDROPYRIDIN 3 YL)METHYL] N METHYL 2 OXO 2H CHROMENE 3 CARBOXAMIDE; 8 QUINOLINOL DERIVATIVE; AMIDE; FLUORESCENT DYE; IRON; PYRIDONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALIBRATION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOLYSIS; DIGITAL IMAGING; FLUORESCENCE; FLUORESCENCE MICROSCOPY; HYDROPHOBICITY; IRON CHELATION; IRON TRANSPORT; LIPOPHILICITY; LIVER CELL; MALE; NONHUMAN; PHOTOCHEMICAL QUENCHING; PRIORITY JOURNAL; RAT; SPECTROPHOTOMETRY; SYNTHESIS;

ANIMALS; CALIBRATION; CELL-FREE SYSTEM; CELLS, CULTURED; FLUORESCENT DYES; HEPATOCYTES; IRON; IRON CHELATING AGENTS; MALE; PYRIDONES; RATS; RATS, WISTAR;

EID: 33645581000     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20051496     Document Type: Article

References (38)

1. Crichton, R. R. (2001) Inorganic Biochemistry of Iron Metabolism, 2nd edn, John Wiley and Sons, Chichester
2. Esposito, B. P., Epsztejn, S., Breuer, W. and Cabantchik, Z. I. (2002) A review of fluorescence methods for assessing labile iron in cells and biological fluids. Anal. Biochem. 304, 1-18
3. Petrat, F., de Groot, H., Sustmann, R. and Rauen, U. (2002) The chelatable iron pool in living cells: a methodically defined quantity. Biol. Chem. 383, 489-502
4. Halliwell, B. and Gutteridge, J. M. C. (1990) Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 186, 1-85
5. Hamed, M. Y., Hider, R. C. and Silver, J. (1982) The competition between enterobactin and glutathione for iron. Inorg. Chim. Acta 66, 13-18
6. Halliwell, B. and Gutteridge, J. M. C. (1999) Free Radicals in Biology and Medicine, 3rd edn, pp. 48-55, Oxford University Press, Oxford, U.K.
7. Aruoma, O. I., Halliwell, B., Gajewski, E. and Dizdaroglu, M. (1989) Damage to the bases in DNA induced by hydrogen peroxide and ferric ion chelates. J. Biol. Chem. 264, 20509-20512
8. Komara, J. S., Nayini, N. R., Bialick, H. A., Indrieri, R. J., Evans, A. T., Garritano, A. M., Hoehner, T. J., Jacobs, W. A., Huang, R. R., Krause, G. S. et al. (1986) Brain iron delocalization and lipid peroxidation following cardiac arrest. Ann. Emerg. Med. 15, 384-389
9. Reddy, B. R., Kloner, R. A. and Przyklenk, K. (1989) Early treatment with deferoxamine limits myocardial ischaemic/reperfusion injury. Free Radical Biol. Med. 7, 45-52
10. Gerlach, M., Ben-Shachar, D., Riederer, P. and Youdim, M. B. H. (1994) Altered brain metabolism of iron as a cause of neurodegenerative disease? J. Neurochem. 63, 793-807
11. Hershko, C., Konijn, A. M. and Link, G. (1998) Iron chelators for thalassaemia. Br. J. Haematol. 101, 399-406
12. Tilbrook, G. S. and Hider, R. C. (1998) Iron chelators for clinical use. In Metal Ions in Biological Systems (Sigel, A. and Sigel, H., eds.), pp. 691-730, Marcel Dekker, New York
13. Liu, Z. D. and Hider, R. C. (2002) Design of clinically useful iron(lll)-selective chelators. Med. Res. Rev. 22, 26-64
14. Porter, J. B., Huehns, E. R. and Hider, R. C. (1989) The development of iron chelating drugs. Baillieres Clin. Haematol. 2, 257-292
15. Porter, J. B., Morgan, J., Hoyes, K. P., Burke, L. C., Huehns, E. R. and Hider, R. C. (1990) Relative oral efficacy and acute toxicity of hydroxypyridin-4-one iron chelators in mice. Blood 76, 2389-2396
16. Porter, J. B., Singh, S., Katherine, P. H., Epemolu, O., Abeysinghe, R. D. and Hider, R. C. (1994) Lessons from preclinical and clinical studies with 1,2-diethyl-3-hydroxypyridin-4-one, CP94 and related compounds. Adv. Exp. Med. Biol. 356, 361-370
17. 59Fe-ferritin-loaded rat model. Biochem. Pharmacol. 57, 559-566
18. Porter, J. B. (1996) Evaluation of new iron chelators for clinical use. Acta Haematol. 95, 13-25
19. Bauminger, E. R., Cohen, S. G., Ofer, S. and Rachmilewitz, E. A. (1979) Quantitative studies of ferritinlike iron in erythrocytes of thalassemia, sickle-cell anemia, and hemoglobin Hammersmith with Mossbauer spectroscopy. Proc. Natl. Acad. Sci. U.S.A. 76, 939-943
20. Bauminger, E. R. and Nowik, I. (1998) Iron in Parkinson disease, blood diseases, malaria and ferritin. Hyperfine Interact. 111, 159-170
21. Gower, J. D., Healing, G. and Green, C. J. (1989) Determination of desferrioxamine-available iron in biological tissues by high-pressure liquid chromatography. Anal. Biochem. 180, 126-130
22. Öllinger, K. and Roberg, K. (1997) Nutrient deprivation of cultured rat hepatocytes increases the desferrioxamine-available iron pool and augments the sensitivity to hydrogen peroxide. J. Biol. Chem. 272, 23707-23711
23. Cammack, R. and Cooper, C. E. (1993) Electron paramagnetic resonance spectroscopy of iron complexes and iron-containing proteins. Methods Enzymol. 227, 353-384
24. Cairo, G., Tacchini, L., Pogliaghi, G., Anzon, E., Tomasi, A. and Bernelli-Zazzera, A. (1995) Induction of ferritin synthesis by oxidative stress. Transcriptional and post-transcriptional regulation by expansion of the 'free' iron pool. J. Biol. Chem. 270, 700-703
25. Flatmark, T. and langeras, A. (1976) Mitochondrial 'non-heme non-FeS iron' and its significance in the cellular metabolism of iron. In Proteins of Iron Metabolism (Brown, E. B., Aisen, P., Fielding, J. and Crichton, R. R., eds.), pp. 349-358, Grune and Stratton, New York
26. Yegorov, D. Y., Kozlov, A. V., Azizova, O. A. and Vladimirov, Y. A. (1993) Simultaneous determination of Fe(III) and Fe(II) in water solutions and tissue homogenates using desferal and 1,10-phenanthroline. Free Radical Biol. Med. 15, 565-574
27. Savory, J. and Herman, M. M. (1999) Advances in instrumental methods for the measurement and speciation of trace metals. Ann. Clin. Lab. Sci. 29, 118-126
28. Breuer, W., Epsztejn, S., Millgram, P. and Cabantchik, Z. I. (1995) Transport of iron and other transition metals into cells as revealed by a fluorescent probe. Am. J. Physiol. 268, C1354-C1361
29. Epsztejn, S., Kakhlon, O., Glickstein, H., Breuer, W. and Cabantchik, Z. I. (1997) Fluorescence analysis of the labile iron pool of mammalian cells. Anal. Biochem. 248, 31-40
30. Petrat, F., Bauen, U. and de Groot, H. (1999) Determination of the chelatable iron pool of isolated rat hepatocytes by digital fluorescence microscopy using the fluorescent probe, phen green SK. Hepatology 29, 1171-1179
31. Petrat, F., de Groot, H. and Rauen, U. (2000) Determination of the chelatable iron pool of single intact cells by laser scanning microscopy. Arch. Biochem. Biophys. 376, 74-81
32. Luo, W., Ma, Y. M., Quinn, P. J., Hider, R. C. and Liu, Z. D. (2004) Design, synthesis and properties of novel iron(III)-specific fluorescent probes. J. Pharm. Pharmacol. 56, 529-536
33. Ma, Y. M., Luo, W., Quinn, P. J., Liu, Z. D. and Hider, B. C. (2004) Design, synthesis, physicochemical properties, and evaluation of novel iron chelators with fluorescent sensors. J. Med. Chem. 47, 6349-6362
34. 2 liberated by sources other than xanthine oxidase. Biol. Chem. Hoppe-Seyler 372, 35-41
35. Lipinski, C. A., Lombardo, F., Dominy, B. W. nd Feeney, P. J. (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development setting. Adv. Drug Deliv. Rev. 23, 3-25
36. 3+ values. Bioorg. Med. Chem. 9, 563-573
37. Scheiber, B. and Goldenberg, H. (1996) Uptake of iron by isolated rat hepatocytes from a hydrophilic impermeable ferric chelate, Fe(III)-DTPA. Arch. Biochem. Biophys. 326, 185-192
38. Sturm, B., Bistrich, U., Schranzhofer, M., Sarsero, J. P., Bauen, U., Scheiber-Mojdehkar, B., de Groot, H., Ioannou, P. and Petrat, F. (2005) Friedreich's ataxia, no changes in mitochondrial labile iron in human lymphoblasts and fibroblasts: a decrease in antioxidative capacity? J. Biol. Chem. 280, 6701-6708